3K.F.Giourano,A.Jatoi,P.J.Stella. Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction:a phase II study from the North Central Cancer Treatment Group[J].Annals of Oncology,2006,(04):652–656.
4Heikki Joensuu,Pirkko-Liisa Kellokumpu-Lehtinen,Riikka Huovinen. Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer:an open-label,randomised controlled trial[J].Lancet Oncology,2009,(12):1145-1151.
5P C Thuss-Patience,A Kretzschmar,Y Dogan. Docetaxel and capecitabine for advanced gastric cancer:in-vestigating dose-dependent efficacy in two patient cohorts[J].British Journal of Cancer,2011,(04):505-512.
6World Health Organization. WHO Global Strategy for Containment of Antimicrobial Resistance [ DB/CD ]. Geneva,2001 ( WHO/CDS/ CSR/DRS/2001.2).
7Arias CA, Murray BE. Antibiotic - resistant bugs in the 21stcentury - a clinical super - challenge [ J ]. NEnglJMed ,2009,360 ( 5 ) :439.
